With multiple marketed medicines and a leading pipeline in neurology, cardiology and select areas of high patient needs, we continue to drive innovation in RNA therapies in addition to advancing new approaches in gene editing to provide greater value to patients and are well positioned financially to deliver on our strategic goals. Collaborate with other Supply chain functions, Commercial Quality, Patient Services and Commercial Distribution, and U.S Market Access, CMC, Regulatory, Legal, Marketing, Finance, Sales, Commercial Analytics, and others, as necessary to support organizational planning and performance needs.